Nuclea Biotechnologies Inc., which has operations in Worcester, announced that federal regulators have classified its cell metabolism measurement device as having low to moderate risk.
Unemployment rates in Central Massachusetts worsened in June but are still down considerably from June of last year, the Patrick administration said Tuesday.
A global expert on computer security will be one of the featured speakers in the Worcester Economic Club's upcoming “speaker series,” the group announced.
Ten Central Massachusetts communities will receive federal community development block grants that total about $6.6 million for a variety of uses, notably housing and infrastructure upgrades.
Karyopharm Therapeutics, a life sciences startup, was a rising star in Natick until the company announced last month it was moving to a bigger headquarters in Newton at the end of July. One reason? There wasn't enough laboratory space to expand.
Home to 11 percent of American drug development and more than a fifth of all U.S. biotech venture capital, Massachusetts has particularly piqued the interests of Israelis with life sciences backgrounds.